Flora Hammond

Flora HammondM.D.

Rehabilitation Hospital of Indiana and Indiana University School of Medicine

Dr. Hammond's research has included outcome prediction and measurement, relationships, mood and behavior, and treatments to improve outcomes. Since 1998 she has served as the Principal Investigator and Director of the Carolinas Traumatic Brain Injury Model System grant funded by the National Institute on Disability Rehabilitation and Research. She also serves as principal investigator of several other Federally-funded research grants including a multicenter study from the National Institute on Disability and Rehabilitation Research to study the use of Amantadine to treat irritability and aggression in individuals with chronic brain injury.  

Disclosures:             

Within the last 24 months, have you rendered, or in the next two years, will you render clinical services or support services (whether diagnostic, therapeutic, educational, case management, or similar) to persons with TBI or their family members and caregivers, as an independent professional or employee of a for-profit or not-for-profit organization?: Employee at Indiana University, Dept of Physical Medicine and Rehabilitation.

Within the past 24 months, I or one of my “immediate family members” received personal compensation for the following: Steering Committee of Prism II Study (Avanir Pharmaceutical); Travel funding for Baylor College of Medicine, Cornell School of Medicine; Mayo Clinic; Rehab Institute of Chicago; Royalties from Lash Publishing for factsheets, tip cards and books, Demos Publishing for book; compensation for time spent as medical consultant; compensation to my department for my services as Medical Director at Neuro Restorative at St. Vincent Hospital, and Chief of Medical Affairs at Rehabilitation Institution Hospital of Indiana, and service line leader of Indiana University Health Physicians.

Within the past 24 months and during the three-year course of the project under consideration, I or one of my immediate family members received or will receive financial or material research support or compensation from the following: NIDRR + NIH

In the past 24 months and during the three-year course of the project under consideration, I or one of my immediate family members: Some min-moderate level of mutual fund for stock ownership in pharmaceutical companies. Investments were made by broker.

In the past 24 months and during the three-year course of the project, I have or will: Expert testimony generally occurs 1-2 times yearly; Prepared affidavit may occur approximately once a year; act as witness/consultant approximately 1-2 times yearly.

Do you have one or more significant nonfinancial competing interests?: Co-chair of the AmericanCongress of Rehabilitation Medican (ACRM) long term; issues SIG + Disorders of Consciousness SIG; Editorial Board of J Head Trauma Rehabilitation

« Back to view all panel members